Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Curr Opin HIV AIDS ; 11(2): 131-7, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26731430

RESUMEN

PURPOSE OF REVIEW: The purpose is to review recent insights into the impact of HIV-associated immune activation on AIDS and non-AIDS morbidity and mortality. RECENT FINDINGS: Immune activation has long been recognized as an important consequence of untreated HIV infection and predictor of AIDS progression, which declines but fails to normalize during suppressive antiretroviral therapy, and continues to predict disease in this setting. Thus, a major research agenda is to develop novel therapies to reduce persistent immune activation in treated HIV infection. Yet, the optimal targets for interventions remain unclear. Both the specific root causes of immune activation and the many interconnected pathways of immune activation that are most likely to drive disease risk in HIV-infected individuals remain incompletely characterized, but recent studies have shed new light on these topics. SUMMARY: In the context of this review, we will summarize recent evidence helping to elucidate the immunologic pathways that appear most strongly predictive of infectious and noninfectious morbidity. We will also highlight the likelihood that not all root drivers of immune activation - and the discrete immunologic pathways to which they give rise - are likely to produce the same disease manifestations and/or be equally attenuated by early antiretroviral therapy initiation.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , VIH-1/inmunología , Progresión de la Enfermedad , Humanos , Fenómenos del Sistema Inmunológico/inmunología , Interferón Tipo I/inmunología , Monocitos/inmunología
2.
PLoS One ; 10(12): e0143883, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26624014

RESUMEN

Migration is crucial for the function of dendritic cells (DCs), which act as outposts of the immune system. Upon detection of pathogens, skin- and mucosa-resident DCs migrate to secondary lymphoid organs where they activate T cells. DC motility relies critically on the actin cytoskeleton, which is regulated by the actin-related protein 2/3 (ARP2/3) complex, a nucleator of branched actin networks. Consequently, loss of ARP2/3 stimulators and upstream Rho family GTPases dramatically impairs DC migration. However, nothing is known yet about the relevance of ARP2/3 inhibitors for DC migration. We previously demonstrated that the AP-1-associated adaptor protein Gadkin inhibits ARP2/3 by sequestering it on intracellular vesicles. Consistent with a role of Gadkin in DC physiology, we here report Gadkin expression in bone marrow-derived DCs and show that its protein level and posttranslational modification are regulated upon LPS-induced DC maturation. DCs derived from Gadkin-deficient mice were normal with regards to differentiation and maturation, but displayed increased actin polymerization. While the actin-dependent processes of macropinocytosis and cell spreading were not affected, loss of Gadkin significantly impaired DC migration in vitro, however, in vivo DC migration was unperturbed suggesting the presence of compensatory mechanisms.


Asunto(s)
Movimiento Celular/inmunología , Células Dendríticas/inmunología , Proteínas de la Membrana/metabolismo , Complejo 2-3 Proteico Relacionado con la Actina/inmunología , Complejo 2-3 Proteico Relacionado con la Actina/metabolismo , Actinas/inmunología , Actinas/metabolismo , Animales , Comunicación Celular/inmunología , Diferenciación Celular/inmunología , Células Dendríticas/metabolismo , Fenómenos del Sistema Inmunológico/inmunología , Activación de Linfocitos/inmunología , Proteínas de la Membrana/inmunología , Ratones , Ratones Endogámicos C57BL , Linfocitos T/inmunología , Linfocitos T/metabolismo , Factor de Transcripción AP-1/inmunología , Factor de Transcripción AP-1/metabolismo , Proteínas de Unión al GTP rho/inmunología , Proteínas de Unión al GTP rho/metabolismo
3.
Vopr Onkol ; 61(4): 556-62, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-26571822

RESUMEN

During recent years much data, accumulated on biology, function and role of dendritic cells (DC) in cancer development, in a new way allow assessing their role in disease process. Identification of features of DC functional state as well as their interaction and influence on the immune cells in tumor growth can be used as a basis for a new approach to cancer therapy enhancing standard therapy efficacy. The review analyzes different mechanisms of escaping of tumor cell from immune surveillance involving DC as one of the main participants of antitumor immune response. Also the prospects of using DC for vaccination are discussed. DC can be promising target for therapeutic strategies and also can be used for formation of antitumor response and cell therapy.


Asunto(s)
Células Dendríticas/inmunología , Fenómenos del Sistema Inmunológico , Neoplasias/inmunología , Antígenos de Neoplasias/inmunología , Vacunas contra el Cáncer/inmunología , Humanos , Fenómenos del Sistema Inmunológico/inmunología , Vigilancia Inmunológica , Neoplasias/prevención & control
5.
PLoS One ; 10(5): e0125586, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25992627

RESUMEN

Natural selection favors individuals that respond with effective and appropriate immune responses to macro or microparasites. Animals living in populations close to ecological carrying capacity experience increased intraspecific competition, and as a result are often in poor nutritional condition. Nutritional condition, in turn, affects the amount of endogenous resources that are available for investment in immune function. Our objective was to understand the relationship between immune function and density dependence mediated by trade-offs between immune function, nutritional condition, and reproduction. To determine how immune function relates to density-dependent processes, we quantified bacteria killing ability, hemolytic-complement activity, and nutritional condition of North American elk (Cervus elaphus) from populations maintained at experimentally high- and low-population densities. When compared with elk from the low-density population, those from the high-density population had higher bacteria killing ability and hemolytic-complement activity despite their lower nutritional condition. Similarly, when compared with adults, yearlings had higher bacteria killing ability, higher hemolytic-complement activity, and lower nutritional condition. Pregnancy status and lactational status did not change either measure of constitutive immunity. Density-dependent processes affected both nutritional condition and investment in constitutive immune function. Although the mechanism for how density affects immunity is ambiguous, we hypothesize two possibilities: (i) individuals in higher population densities and in poorer nutritional condition invested more into constitutive immune defenses, or (ii) had higher parasite loads causing higher induced immune responses. Those explanations are not mutually exclusive, and might be synergistic, but overall our results provide stronger support for the hypothesis that animals in poorer nutritional condition invest more in constitutive immune defenses then animals in better nutritional condition. This intriguing hypothesis should be investigated further within the larger framework of the cost and benefit structure of immune responses.


Asunto(s)
Ciervos/inmunología , Ciervos/fisiología , Fenómenos del Sistema Inmunológico/inmunología , Fenómenos del Sistema Inmunológico/fisiología , Selección Genética/fisiología , Animales , Densidad de Población , Reproducción/inmunología , Reproducción/fisiología , Selección Genética/inmunología , Estados Unidos
6.
J Immunol Res ; 2014: 962047, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25371910

RESUMEN

Dendritic cells (DCs) are major immune components, and depending on how these cells are modulated, the protective host immune response changes drastically. Trypanosoma cruzi is a parasite with high genetic variability and modulates DCs by interfering with their capacity for antigen recognition, migration, and maturation. Despite recent efforts, the association between DCs and T. cruzi I (TcI) and TcII populations is unknown. Herein, it was demonstrated that AQ1.7 and MUTUM TcI strains present low rates of invasion of bone marrow-derived DCs, whereas the 1849 and 2369 TcII strains present higher rates. Whereas the four strains similarly induced the expression of PD-L1, the production and expression of IL-10 and TLR-2, respectively, in DCs were differentially increased. The production of TNF-α, IL-12, IL-6, and CCL2 and the expression of CD40, CD80, MHC-II, CCR5, and CCR7 changed depending on the strain. The 2369 strain yielded the most remarkable results because greater invasion correlated with an increase in the levels of anti-inflammatory molecules IL-10 and PD-L1 but not with a change in the levels of TNF-α, MHC-II, or CD40 molecules. These results suggest that T. cruzi strains belonging to different populations have evolved specific evasion strategies that subvert DCs and consequently the host response.


Asunto(s)
Células Dendríticas/inmunología , Interacciones Huésped-Parásitos/inmunología , Fenómenos del Sistema Inmunológico/inmunología , Trypanosoma cruzi/inmunología , Animales , Antígeno B7-1/inmunología , Antígeno B7-1/metabolismo , Antígeno B7-H1/inmunología , Antígeno B7-H1/metabolismo , Antígenos CD40/inmunología , Antígenos CD40/metabolismo , Células Dendríticas/metabolismo , Células Dendríticas/parasitología , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Antígenos de Histocompatibilidad Clase II/inmunología , Antígenos de Histocompatibilidad Clase II/metabolismo , Interleucina-10/inmunología , Interleucina-10/metabolismo , Interleucina-12/inmunología , Interleucina-12/metabolismo , Interleucina-6/inmunología , Interleucina-6/metabolismo , Ratones Endogámicos C57BL , Receptores CCR2/inmunología , Receptores CCR2/metabolismo , Receptores CCR5/inmunología , Receptores CCR5/metabolismo , Receptores CCR7/inmunología , Receptores CCR7/metabolismo , Especificidad de la Especie , Receptor Toll-Like 2/inmunología , Receptor Toll-Like 2/metabolismo , Trypanosoma cruzi/clasificación , Trypanosoma cruzi/fisiología , Factor de Necrosis Tumoral alfa/inmunología , Factor de Necrosis Tumoral alfa/metabolismo
7.
Mayo Clin Proc ; 89(4): 520-35, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24684874

RESUMEN

Similarities between the pathologic progression of cancer and the physiologic process of placentation (eg, proliferation, invasion, and local/systemic tolerance) have been recognized for many years. Sex hormones such as human chorionic gonadotropin, estrogens, progesterone, and others contribute to induction of immunologic tolerance at the beginning of gestation. Sex hormones have been shown to play contributory roles in the growth of cancers such as breast cancer, prostrate cancer, endometrial cancer, and ovarian cancer, but their involvement as putative mediators of the immunologic escape of cancer is still being elucidated. Herein, we compare the emerging mechanism by which sex hormones modulate systemic immunity in pregnancy and their potentially similar role in cancer. To do this, we conducted a PubMed search using combinations of the following keywords: "immune regulation," "sex hormones," "pregnancy," "melanoma," and "cancer." We did not limit our search to specific publication dates. Mimicking the maternal immune response to pregnancy, especially in late gestation, might aid in design of better therapies to reconstitute endogenous antitumor immunity and improve survival.


Asunto(s)
Hormonas Esteroides Gonadales/inmunología , Inmunomodulación/fisiología , Melanoma/inmunología , Complicaciones Neoplásicas del Embarazo/inmunología , Neoplasias Cutáneas/inmunología , Adulto , Gonadotropina Coriónica/inmunología , Gonadotropina Coriónica/metabolismo , Gonadotropina Coriónica/uso terapéutico , Estrógenos/inmunología , Estrógenos/metabolismo , Estrógenos/uso terapéutico , Femenino , Edad Gestacional , Hormonas Esteroides Gonadales/metabolismo , Hormonas Esteroides Gonadales/uso terapéutico , Humanos , Fenómenos del Sistema Inmunológico/inmunología , Fenómenos del Sistema Inmunológico/fisiología , Factores Inmunológicos , Inmunomodulación/inmunología , Melanoma/tratamiento farmacológico , Melanoma/patología , Embarazo , Complicaciones Neoplásicas del Embarazo/tratamiento farmacológico , Complicaciones Neoplásicas del Embarazo/patología , Progesterona/inmunología , Progesterona/metabolismo , Progesterona/uso terapéutico , Pronóstico , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Resultado del Tratamiento
8.
Biomed J ; 37(2): 34-40, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24732657

RESUMEN

Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system in which destruction of myelin and nerve axons has been shown to be mediated by immune mechanisms. Although the focus of research has been traditionally on T cells as key mediators of the immunopathology, more recent efforts at understanding this complex disorder have been directed increasingly at other cellular and humoral elements of the immune response. This review is a reappraisal of the crucial role of T cells, in particular the CD4+ helper T-cell subset, in multiple sclerosis. Recent evidence is discussed underlining the predominant contribution of T-cell-associated genes to the genome-wide association study results of multiple sclerosis susceptibility, the loss of T-cell quiescence in the conversion from clinically isolated syndrome to clinically definite multiple sclerosis, and the fact that T cells represent the main target of effective immunomodulatory and immunosuppressive treatments in multiple sclerosis.


Asunto(s)
Sistema Nervioso Central/inmunología , Fenómenos del Sistema Inmunológico/inmunología , Esclerosis Múltiple/terapia , Linfocitos T/inmunología , Animales , Linfocitos B/citología , Linfocitos B/inmunología , Humanos , Inmunoterapia , Esclerosis Múltiple/diagnóstico , Esclerosis Múltiple/inmunología , Linfocitos T/citología
9.
Lab Invest ; 93(1): 72-80, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23147225

RESUMEN

TNF-α-converting enzyme (TACE) can cleave transmembrane proteins, such as TNF-α, TNF receptors, and epidermal growth factor receptor (EGFR) ligands, to release the extracellular domains from the cell surface. Recent studies have suggested that overexpression of TACE may be associated with the pathogenesis of inflammation and fibrosis. To determine the roles of TACE in inflammation and fibrosis, TACE transgenic (TACE-Tg) mice, which overexpressed TACE systemically, were generated. As the transgene-derived TACE was expressed as an inactive form, no spontaneous phenotype developed in TACE-Tg mice. However, the transgene-derived TACE could be converted to an active form by furin in vitro and by phorbol myristate acetate (PMA) in vivo. Subcutaneous injection of PMA into mice induced inflammatory cell infiltration 1 day later and subsequent dermal fibrosis 7 days later. Interestingly, the degree of dermal fibrosis at day 7 was significantly higher in TACE-Tg mice than in wild-type mice. Correspondingly, PMA increased the expression of type I collagen in the primary culture of dermal fibroblasts derived from TACE-Tg mice. Furthermore, phosphorylated EGFR was increased in the fibroblasts by the PMA treatment. The collective findings suggest that TACE overexpression and activation in fibroblasts could shed off putative EGFR ligands. Subsequently, the soluble EGFR ligands could bind and activate EGFR on fibroblasts, and then increase the type I collagen expression resulting in induction of dermal fibrosis. These results also suggest that TACE and EGFR on fibroblasts may be novel therapeutic targets of dermal fibrosis, which is induced after diverse inflammatory disorders of the skin.


Asunto(s)
Proteínas ADAM/biosíntesis , Fibroblastos/enzimología , Inflamación/enzimología , Proteínas ADAM/genética , Proteínas ADAM/metabolismo , Proteína ADAM17 , Animales , Colágeno Tipo I/metabolismo , Receptores ErbB/metabolismo , Femenino , Fibroblastos/inmunología , Fibrosis/enzimología , Fibrosis/inmunología , Furina/farmacología , Histocitoquímica , Fenómenos del Sistema Inmunológico/efectos de los fármacos , Fenómenos del Sistema Inmunológico/inmunología , Inflamación/inmunología , Ratones , Ratones Transgénicos , Piel/química , Piel/inmunología , Piel/patología , Acetato de Tetradecanoilforbol/farmacología
10.
Animal ; 6(2): 305-10, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22436189

RESUMEN

Two experiments (EXPs) were conducted to evaluate models of immune system stimulation (ISS) that can be used in nutrient metabolism studies in growing pigs. In EXP I, the pig's immune response to three non-pathogenic immunogens was evaluated, whereas in EXP II the pig's more general response to one of the immunogens was contrasted with observations on non-ISS pigs. In EXP I, nine growing barrows were fitted with a jugular catheter, and after recovery assigned to one of three treatments. Three immunogens were tested during a 10-day ISS period: (i) repeated injection of increasing amounts of Escherichia coli lipopolysaccharide (LPS); (ii) repeated subcutaneous injection of turpentine (TURP); and (iii) feeding grains naturally contaminated with mycotoxins (MYCO). In EXP II, 36 growing barrows were injected repeatedly with either saline (n = 12) or increasing amounts of LPS (n = 24) for 7 days (initial dose 60 µg/kg body weight). Treating pigs with TURP and LPS reduced feed intake (P < 0.02), whereas feed intake was not reduced in pigs on MYCO. Average daily gain (ADG; kg/day) of pigs on LPS (0.50) was higher than that of pigs on TURP (0.19), but lower than that of pigs on MYCO (0.61; P < 0.01). Body temperature was elevated in pigs on LPS and TURP, by 0.8°C and 0.7°C, respectively, relative to pre-ISS challenge values (39.3°C; P < 0.02), but remained unchanged in pigs on MYCO. Plasma concentrations of interleukin-1ß were increased in pigs treated with LPS and TURP (56% and 55%, respectively, relative to 22.3 pg/ml for pre-ISS; P < 0.01), but not in MYCO-treated pigs. Plasma cortisol concentrations remained unchanged for pigs on MYCO and TURP, but were reduced in LPS-treated pigs (30% relative to 29.8 ng/ml for pre-ISS; P < 0.05). Red blood cell glutathione concentrations were lower in TURP-treated pigs (13% relative to 1.38 µM for pre-ISS; P < 0.05), but were unaffected in pigs on LPS and MYCO. In EXP I, TURP caused severe responses including skin ulceration and substantial reductions in feed intake and ADG, whereas MYCO did not induce effective ISS. In EXP II, ISS increased relative organ weights, eye temperature, white blood cell count and plasma acute-phase proteins (P < 0.05), confirming that repeated injection with increasing amounts of LPS induced chronic and relatively mild ISS. Repeated injection with increasing amounts of LPS is a suitable model for studying nutrient metabolism and evaluating the efficacy of nutritional intervention during chronic ISS in growing pigs.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales/inmunología , Enfermedad Crónica , Modelos Animales de Enfermedad , Fenómenos del Sistema Inmunológico/inmunología , Sus scrofa/crecimiento & desarrollo , Sus scrofa/inmunología , Animales , Temperatura Corporal/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Escherichia coli/química , Glutatión/metabolismo , Hidrocortisona/sangre , Interleucina-1beta/sangre , Lipopolisacáridos/efectos adversos , Lipopolisacáridos/inmunología , Micotoxinas/efectos adversos , Micotoxinas/inmunología , Trementina/efectos adversos , Aumento de Peso/efectos de los fármacos
12.
PLoS One ; 6(12): e28917, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22194949

RESUMEN

Food allergy affects approximately 5% of children and is the leading cause of hospitalization for anaphylactic reactions in westernized countries. However, the pathways of anaphylaxis in food allergy are still relatively unknown. We investigated the effector pathways of allergic and anaphylactic responses of different strains of mice in a clinical relevant model of peanut allergy. C3H/HeOuJ, C57BL/6 and BALB/c mice were sensitized by intragastric peanut extract and challenged by intragastric or intraperitoneal injection of peanut. Peanut-specific T cell responses, IgE, IgG1 and IgG2a and mucosal mast cell degranulation were induced to different extent in C3H/HeOuJ, C57BL/6 and BALB/c mice. Interestingly, anaphylactic symptoms after systemic challenge were highest in C3H/HeOuJ followed by C57BL/6 but were absent in BALB/c mice. Mechanistic studies showed that the food allergic systemic anaphylaxis was dependent on platelets, FcRγ and mast cells, and partially dependent on platelet activating factor and monocytes/macrophages, depending on mouse strain. These data demonstrate that in three mouse strains, components of the classic and alternative anaphylactic cascade are differently expressed, leading to differential outcomes in parameters of allergic disease and food induced systemic anaphylaxis.


Asunto(s)
Anafilaxia/inmunología , Fenómenos del Sistema Inmunológico/inmunología , Hipersensibilidad al Cacahuete/inmunología , Animales , Formación de Anticuerpos/inmunología , Especificidad de Anticuerpos/inmunología , Plaquetas/metabolismo , Degranulación de la Célula/inmunología , Oído/patología , Inmunidad Humoral/inmunología , Inmunización , Leucocitos/inmunología , Mastocitos/fisiología , Ratones , Ratones Endogámicos , Membrana Mucosa/inmunología , Membrana Mucosa/patología , Extractos Vegetales/efectos adversos , Extractos Vegetales/inmunología , Factor de Activación Plaquetaria/metabolismo , Linfocitos T/inmunología
13.
Crit Care Clin ; 26(4): 629-31, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20970048

RESUMEN

A growing body of literature suggests multifaceted alterations to the immune function in obese patients compared with a lean cohort. Although treatment in the intensive care unit has an associated risk of infectious complications, which, if any, of these immunologic alterations are causal is unclear. Obesity clearly causes abundant alterations to the immune system. Overall, the aggregate effect seems to be chronic activation of inflammatory mediators.


Asunto(s)
Tejido Adiposo Blanco/inmunología , Obesidad/inmunología , Adipoquinas/inmunología , Humanos , Fenómenos del Sistema Inmunológico/inmunología , Inflamación/inmunología
14.
Immunol Rev ; 236: 176-89, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20636817

RESUMEN

Measles is an important cause of child mortality that has a seemingly paradoxical interaction with the immune system. In most individuals, the immune response is successful in eventually clearing measles virus (MV) infection and in establishing life-long immunity. However, infection is also associated with persistence of viral RNA and several weeks of immune suppression, including loss of delayed type hypersensitivity responses and increased susceptibility to secondary infections. The initial T-cell response includes CD8+ and T-helper 1 CD4+ T cells important for control of infectious virus. As viral RNA persists, there is a shift to a T-helper 2 CD4+ T-cell response that likely promotes B-cell maturation and durable antibody responses but may suppress macrophage activation and T-helper 1 responses to new infections. Suppression of mitogen-induced lymphocyte proliferation can be induced by lymphocyte infection with MV or by lymphocyte exposure to a complex of the hemagglutinin and fusion surface glycoproteins without infection. Dendritic cells (DCs) are susceptible to infection and can transmit infection to lymphocytes. MV-infected DCs are unable to stimulate a mixed lymphocyte reaction and can induce lymphocyte unresponsiveness through expression of MV glycoproteins. Thus, multiple factors may contribute both to measles-induced immune suppression and to the establishment of durable protective immunity.


Asunto(s)
Fenómenos del Sistema Inmunológico/inmunología , Virus del Sarampión/inmunología , Sarampión/inmunología , Linfocitos T/inmunología , Linfocitos B/inmunología , Niño , Células Dendríticas/inmunología , Interacciones Huésped-Patógeno/inmunología , Humanos , Sarampión/virología , Virus del Sarampión/fisiología
15.
Int Arch Allergy Immunol ; 152 Suppl 1: 83-9, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20523069

RESUMEN

BACKGROUND: Recent studies suggest that probiotics alleviate pathophysiological processes of allergic diseases and inflammatory bowel diseases, whereas 'non-probiotic' microflora has negative effects. However, the underlying mechanisms are not well known, especially in relation to eosinophils, the major effector cells of these inflammatory diseases. OBJECTIVE: To investigate the effects of probiotic Bifidobacterium bifidum (BB) on human eosinophil functions compared with pathogenic Clostridium difficile (CD). METHODS: Peripheral human eosinophils were cultured with heat-killed BB or CD. FISH-labeled CD and BB were incubated with eosinophils visualized by confocal laser scanning microscopy. Superoxide generation and degranulation of eosinophils were measured with the cytochrome c reduction method and the eosinophil-derived neurotoxin (EDN) release assay, respectively. RESULTS: Confocal microscopy revealed that Cy3-labeled CD and BB were apparently ingested by eosinophils. Both bacteria induced minimal superoxide generation. However, CD elicited significantly higher EDN release than BB. GM-CSF significantly enhanced EDN release by CD but not by BB. Bacterial-induced EDN release was calcium dependent. CONCLUSION: The beneficial effect of probiotic BB might be explained, at least in part, by its ability to decrease EDN release from eosinophils compared with 'pathogenic' CD.


Asunto(s)
Bifidobacterium/inmunología , Clostridioides difficile/inmunología , Eosinófilos/inmunología , Fenómenos del Sistema Inmunológico/inmunología , Probióticos , Degranulación de la Célula/efectos de los fármacos , Degranulación de la Célula/inmunología , Ácido Egtácico/farmacología , Neurotoxina Derivada del Eosinófilo/metabolismo , Eosinófilos/metabolismo , Factor Estimulante de Colonias de Granulocitos y Macrófagos/farmacología , Humanos , Toxina del Pertussis/farmacología , Fagocitosis/inmunología , Superóxidos/metabolismo , Factor de Necrosis Tumoral alfa/farmacología
16.
Int J Radiat Biol ; 86(5): 409-19, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20397846

RESUMEN

PURPOSE: Exposure to various forms of radiation, including iron ions that have an exceptionally high biological effectiveness, is an inevitable consequence of spaceflight. However, genetic background can significantly influence the response to radiation and hence also the overall health of crewmembers. The major goal of this study was to compare leukocyte population responses in two strains of mice that differ in susceptibility to radiation: C57BL/6 (resistant) and CBA/Ca (susceptible). MATERIALS AND METHODS: The mice were whole-body irradiated with 0, 50, 200, or 300 cGy (56)Fe(26) (1 GeV) at approximately 1 Gy/min and euthanised on days 4 and 30 thereafter for analyses. Analyses included body and organ masses (spleen, liver, thymus, lungs), distribution of leukocyte populations in blood and spleen, red blood cell and platelet characteristics, expression of surface molecules (CD11b, CD54), and spontaneous and mitogen-induced blastogenesis. RESULTS: There were main effects of Dose and Dose x Day interactions on virtually all quantified parameters in both strains of mice. In contrast, there were relatively few Dose x Strain and three-way interactions. Strain-related interactions involved changes in circulating phagocytic populations, erythrocytes, and liver mass. CONCLUSION: The data demonstrate that genetic background can modify certain immune-related parameters after exposure to heavy particle radiation. The possible implications of these findings are discussed.


Asunto(s)
Fenómenos del Sistema Inmunológico/efectos de la radiación , Radioisótopos de Hierro/toxicidad , Leucocitos/efectos de la radiación , Irradiación Corporal Total/efectos adversos , Animales , Antígenos CD/efectos de la radiación , Plaquetas/efectos de la radiación , Peso Corporal/efectos de la radiación , Relación Dosis-Respuesta en la Radiación , Exposición a Riesgos Ambientales , Fenómenos del Sistema Inmunológico/inmunología , Fenómenos del Sistema Inmunológico/fisiología , Leucocitos/citología , Leucocitos/inmunología , Leucocitos/metabolismo , Hígado/efectos de la radiación , Activación de Linfocitos/efectos de la radiación , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Tamaño de los Órganos/efectos de la radiación , Especificidad de Órganos/efectos de la radiación , Fagocitos/citología , Fagocitos/inmunología , Fagocitos/metabolismo , Fagocitos/efectos de la radiación , Tolerancia a Radiación , Especificidad de la Especie , Factores de Tiempo
17.
Radiats Biol Radioecol ; 49(5): 517-27, 2009.
Artículo en Ruso | MEDLINE | ID: mdl-19947514

RESUMEN

In the overview it is shown that immune response to ionizing radiation exposure is determined not only by dose and dose rate, as was believed earlier, but also by a complex of factors (individual's age at exposure, genetic status, etc.). The emphasis in the overview is made on analyses of factors of endogenous (antioxidants, cytokines, peptides, etc.) and exogenous nature which are capable of modifying immune response following radiation exposure.


Asunto(s)
Fenómenos del Sistema Inmunológico/efectos de la radiación , Traumatismos por Radiación/inmunología , Factores de Edad , Animales , Relación Dosis-Respuesta en la Radiación , Genotipo , Homeostasis/inmunología , Humanos , Fenómenos del Sistema Inmunológico/genética , Fenómenos del Sistema Inmunológico/inmunología , Radiación Ionizante
18.
Mayo Clin Proc ; 84(11): 985-1000, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19880689

RESUMEN

Many proliferative, invasive, and immune tolerance mechanisms that support normal human pregnancy are also exploited by malignancies to establish a nutrient supply and evade or edit the host immune response. In addition to the shared capacity for invading through normal tissues, both cancer cells and cells of the developing placenta create a microenvironment supportive of both immunologic privilege and angiogenesis. Systemic alterations in immunity are also detectable, particularly with respect to a helper T cell type 2 polarization evident in advanced cancers and midtrimester pregnancy. This review summarizes the similarities between growth and immune privilege in cancer and pregnancy and identifies areas for further investigation. Our PubMed search strategy included combinations of terms such as immune tolerance, pregnancy, cancer, cytokines, angiogenesis, and invasion. We did not place any restrictions on publication dates. The knowledge gained from analyzing similarities and differences between the physiologic state of pregnancy and the pathologic state of cancer could lead to identification of new potential targets for cancer therapeutic agents.


Asunto(s)
Antineoplásicos/inmunología , Transformación Celular Neoplásica/inmunología , Invasividad Neoplásica/inmunología , Neoplasias/tratamiento farmacológico , Neoplasias/inmunología , Embarazo/inmunología , Centros Médicos Académicos , Antineoplásicos/uso terapéutico , Movimiento Celular/inmunología , Proliferación Celular , Transformación Celular Neoplásica/patología , Sistemas de Liberación de Medicamentos , Femenino , Humanos , Fenómenos del Sistema Inmunológico/inmunología , Fenómenos del Sistema Inmunológico/fisiología , Factores Inmunológicos , Minnesota , Invasividad Neoplásica/patología , Neoplasias/patología , Neovascularización Patológica/inmunología , Tercer Trimestre del Embarazo
19.
Cell Mol Immunol ; 6(5): 317-26, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19887044

RESUMEN

It has long been known that the brain is an immunologically privileged site in normal conditions. Although the cascade of immune responses can occur as long as there is a neuronal injury or a potent immune stimulation, how the brain keeps glial cells in a quiescent state is still unclear. Increasing efforts have been made by several laboratories to elucidate how repression of immune responses is achieved in the neuronal environment. The suppression factors include neurotransmitters, neurohormones, neurotrophic factors, anti-inflammatory factors, and cell-cell contact via adhesion molecules or CD200 receptor. This review discusses how these factors affect the cascade of cerebral immune responses because no single factor listed above can fully account for the immune suppression. While several factors contribute to the suppression of immune responses, activation of glial cells and their production of pro-inflammatory factors do occur as long as there is a neuronal injury, suggesting that some neuronal components facilitate immune responses. This review also discusses which signals initiate or augment cerebral immune responses so that stimulatory signals override the suppressive signals. Increasing lines of evidence have demonstrated that immune responses in the brain are not always detrimental to neurons. Attempt to simply clear off inflammatory factors in the CNS may not be appropriate for neurons in neurological disorders. Appropriate control of immune cells in the CNS may be beneficial to neurons or even neuroregeneration. Therefore, understanding the mechanisms underlying immune suppression may help us to reshape pharmacological interventions against inflammation in many neurological disorders.


Asunto(s)
Encefalopatías/inmunología , Sistema Nervioso Central/inmunología , Fenómenos del Sistema Inmunológico/inmunología , Neuroglía/inmunología , Transducción de Señal/inmunología , Animales , Encefalopatías/fisiopatología , Encefalopatías/terapia , Sistema Nervioso Central/citología , Sistema Nervioso Central/metabolismo , Humanos , Inmunoterapia , Inflamación/inmunología , Inflamación/fisiopatología , Inflamación/prevención & control , Neuroglía/metabolismo , Neuroinmunomodulación
20.
Cytokine ; 48(1-2): 144-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19666230

RESUMEN

Inflammatory bowel disease is a disease that reflects a disequilibrium in host-commensal homeostasis. T-bet-/-xRAG2-/- deficient mice develop a spontaneous juvenile ulcerative colitis resulting from a pro-inflammatory response to the commensal microbiota that is dendritic cell and TNF-alpha driven [schematized in Fig. 1]. The TRUC (T-bet-/- RAG2-/- ulcerative colitis) model is discussed in the broader context of the adaptive and innate immune mechanisms that regulate host-commensal relationships within the intestine.


Asunto(s)
Proteínas de Unión al ADN , Homeostasis/inmunología , Enfermedades Inflamatorias del Intestino , Proteínas de Dominio T Box , Animales , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/inmunología , Células Dendríticas/inmunología , Humanos , Fenómenos del Sistema Inmunológico/inmunología , Enfermedades Inflamatorias del Intestino/inmunología , Enfermedades Inflamatorias del Intestino/microbiología , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Ratones , Ratones Noqueados , Proteínas de Dominio T Box/genética , Proteínas de Dominio T Box/inmunología , Linfocitos T Reguladores/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...